Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas J Dickens

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Plos One|December 30, 2008
Genome-wide co-expression analysis in multiple tissuesIan C Grieve, Nicholas J Dickens, Michal Pravenec, et al.
Nucleic Acids Research|December 26, 2001
Recent improvements to the SMART domain-based sequence annotation resourceIvica Letunic, Leo Goodstadt, Nicholas J Dickens, et al.
Plos Neglected Tropical Diseases|November 9, 2021
Transcriptional differentiation of Trypanosoma brucei during in vitro acquisition of resistance to acoziborolePieter C Steketee, Federica Giordani, Isabel M Vincent, et al.
Plos Genetics|October 24, 2006
Heritability and tissue specificity of expression quantitative trait lociEnrico Petretto, Jonathan Mangion, Nicholas J Dickens, et al.
Blood|April 28, 2010
XBP1s levels are implicated in the biology and outcome of myeloma mediating different clinical outcomes to thalidomide-based treatmentsTina Bagratuni, Ping Wu, David Gonzalez de Castro, et al.
Haematologica|December 9, 2008
MMSET deregulation affects cell cycle progression and adhesion regulons in t(4;14) myeloma plasma cellsJose L R Brito, Brian Walker, Matthew Jenner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
Homozygous deletion mapping in myeloma samples identifies genes and an expression signature relevant to pathogenesis and outcomeNicholas J Dickens, Brian A Walker, Paola E Leone, et al.
Ebiomedicine|October 1, 2018
A Leishmania infantum genetic marker associated with miltefosine treatment failure for visceral leishmaniasisJuliana B T Carnielli, Kathryn Crouch, Sarah Forrester, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2011
Genetic factors underlying the risk of thalidomide-related neuropathy in patients with multiple myelomaDavid C Johnson, Sophie L Corthals, Brian A Walker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2008
Deletions of CDKN2C in multiple myeloma: biological and clinical implicationsPaola E Leone, Brian A Walker, Matthew W Jenner, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Plos One|December 30, 2008
Genome-wide co-expression analysis in multiple tissuesIan C Grieve, Nicholas J Dickens, Michal Pravenec, et al.
Nucleic Acids Research|December 26, 2001
Recent improvements to the SMART domain-based sequence annotation resourceIvica Letunic, Leo Goodstadt, Nicholas J Dickens, et al.
Plos Neglected Tropical Diseases|November 9, 2021
Transcriptional differentiation of Trypanosoma brucei during in vitro acquisition of resistance to acoziborolePieter C Steketee, Federica Giordani, Isabel M Vincent, et al.
Plos Genetics|October 24, 2006
Heritability and tissue specificity of expression quantitative trait lociEnrico Petretto, Jonathan Mangion, Nicholas J Dickens, et al.
Blood|April 28, 2010
XBP1s levels are implicated in the biology and outcome of myeloma mediating different clinical outcomes to thalidomide-based treatmentsTina Bagratuni, Ping Wu, David Gonzalez de Castro, et al.
Haematologica|December 9, 2008
MMSET deregulation affects cell cycle progression and adhesion regulons in t(4;14) myeloma plasma cellsJose L R Brito, Brian Walker, Matthew Jenner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
Homozygous deletion mapping in myeloma samples identifies genes and an expression signature relevant to pathogenesis and outcomeNicholas J Dickens, Brian A Walker, Paola E Leone, et al.
Ebiomedicine|October 1, 2018
A Leishmania infantum genetic marker associated with miltefosine treatment failure for visceral leishmaniasisJuliana B T Carnielli, Kathryn Crouch, Sarah Forrester, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2011
Genetic factors underlying the risk of thalidomide-related neuropathy in patients with multiple myelomaDavid C Johnson, Sophie L Corthals, Brian A Walker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2008
Deletions of CDKN2C in multiple myeloma: biological and clinical implicationsPaola E Leone, Brian A Walker, Matthew W Jenner, et al.
Pageof 3